Characteristics | total | Abnormal expression | Normal expression | p | χ2 |
---|---|---|---|---|---|
Summary | 106 | 54 | 52 | Â | Â |
Age | |||||
  ≥ 60 | 52 | 27 | 25 | 0.843 | 0.039 |
  < 60 | 54 | 27 | 27 | ||
Overall survival | |||||
 Death | 32 | 25 | 7 | 0.001* | 20.161 |
 Survival | 74 | 19 | 45 | ||
Stage of cancer (FIGO) | |||||
 IV and IIIC recurrent | 78 | 47 | 31 | 0.001* | 10.248 |
 IIIC and less than IIIC | 28 | 7 | 21 | ||
Age of first birth | |||||
  ≥ 24y | 50 | 26 | 24 | 0.838 | 0.042 |
  < 24y | 54 | 27 | 27 | ||
 Childless | 2 | 1 | 1 |  |  |
HE4 | |||||
 Abnormal | 58 | 40 | 18 | 0.001* | 16.646 |
 Normal | 48 | 14 | 34 | ||
CA125 | |||||
 Abnormal | 89 | 47 | 42 | 0.539 | 0.773 |
 Normal | 17 | 7 | 10 |  |  |
Case type | |||||
 Serous carcinoma | 83 | 51 | 32 | 0.001* | 16.883 |
 Other | 23 | 3 | 20 |  |  |
Ascites | |||||
 Yes | 74 | 48 | 26 | 0.001* | 19.010 |
 No | 32 | 6 | 26 |  |  |
Residual tumor | |||||
 Yes | 56 | 31 | 25 | 0.849 | 0.036 |
 No | 50 | 23 | 27 |  |  |